A 3-year-old boy from Delhi presents with a 2-day history of fever (39.5°C), irritability, and neck stiffness. On examination, he has a positive Kernig sign and Brudzinski sign. CSF analysis shows: WBC 450/μL (80% neutrophils), protein 180 mg/dL, glucose 25 mg/dL (serum glucose 90 mg/dL), and Gram stain reveals pleomorphic Gram-negative coccobacilli. Blood culture is pending. The child has not received Hib vaccination. What is the most likely causative organism and the most appropriate immediate antibiotic regimen?

Explanation

## Clinical Diagnosis **Key Point:** The combination of pleomorphic Gram-negative coccobacilli on Gram stain, meningitis in an unvaccinated child aged 3 years, and CSF findings (hypoglycorrhachia, elevated protein, neutrophilic pleocytosis) is pathognomonic for *Haemophilus influenzae* type b (Hib) meningitis. ## Organism Identification | Feature | Hib | N. meningitidis | S. pneumoniae | | --- | --- | --- | --- | | **Gram stain morphology** | Pleomorphic coccobacilli | Gram-negative diplococci (kidney/coffee bean) | Gram-positive diplococci | | **Age of peak incidence** | <5 years (pre-vaccine) | Any age, peaks adolescence | <2 years, >50 years | | **Vaccination status** | Unvaccinated = high risk | No vaccine impact here | Pneumococcal vaccine relevant | | **CSF glucose** | Typically <40% serum | Usually <50% serum | Variable, often <50% serum | **High-Yield:** The pleomorphic Gram-negative coccobacillus morphology is the diagnostic hallmark — no other meningitis pathogen has this appearance. ## Antibiotic Management **Clinical Pearl:** In meningitis, empiric therapy must cover *Hib* until excluded, especially in unvaccinated children. The standard empiric regimen for bacterial meningitis in children is **third-generation cephalosporin (ceftriaxone 2 g IV Q12H) + vancomycin (15–20 mg/kg Q6H)** to cover: - Hib (cephalosporin-susceptible) - Penicillin-resistant *S. pneumoniae* (vancomycin) - *N. meningitidis* (cephalosporin) **Warning:** Penicillin G alone is inadequate for empiric meningitis coverage in the modern era due to emerging resistance in *S. pneumoniae* and the need to cover *Hib*. **Mnemonic:** **CHVP** — Cephalosporin + vancomycin for empiric meningitis in children and high-risk adults. ## Pathogenesis & Epidemiology 1. Hib colonizes nasopharynx → invasion across mucosa 2. Bacteremia → crossing blood–brain barrier via endothelial injury 3. Meningeal inflammation → CSF hypoglycorrhachia (glucose consumption by bacteria and WBCs) 4. Peak incidence <5 years in unvaccinated populations; rare in Hib-vaccinated cohorts **High-Yield:** Hib meningitis is now uncommon in India's urban vaccinated populations but remains a risk in unvaccinated or incompletely vaccinated children. [cite:Harrison 21e Ch 149]